Roth MKM lowered the firm’s price target on Core Scientific (CORZ) to $23 from $25.50 but keeps a Buy rating on the shares. The company expanded its CoreWeave partnership, pushing the contract value past $10B, while the management emphasized diversification and power expansion, the analyst tells investors in a research note. With 300MW of expansion potential and ongoing discussions with hyperscalers, Core Scientific appears well-positioned, the firm adds.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CORZ:
- Core Scientific Inc’s Strategic Expansion and Revenue Growth Potential: Analyst Recommends Buy
- Core Scientific Expands Denton Facility with CoreWeave
- Core Scientific Inc’s Strategic Growth and Robust Demand Justify Buy Rating and $17 Price Target
- Core Scientific Reports Q4 2024 Financial Results
- Closing Bell Movers: Snowflake up 11%, Nvidia little changed after earnings
